CA CYFRA 21-1 LUNG CANCER MARKER Test
Test Name: CA CYFRA 21-1 LUNG CANCER MARKER Test
Components: CYFRA 21-1
Price: 640.0 AED
Sample Condition: 2 mL (0.5 mL min.) serum from 1 SST. Ship refrigerated or frozen. Provide brief clinical history.
Report Delivery: 1 week
Method: Electrochemiluminescence
Test type: Cancer
Doctor: Oncologist, Chest Physician
Test Department: DNA Labs UAE
Pre Test Information
Provide brief clinical history.
Test Details
CYFRA 21-1 is a tumor marker used for the detection and monitoring of lung cancer. It measures the levels of cytokeratin 19 fragments in the blood, which are released by lung cancer cells.
The CYFRA 21-1 test is commonly used in combination with other diagnostic tests, such as imaging scans and biopsies, to help diagnose lung cancer and determine its stage. It can also be used to monitor the effectiveness of treatment and detect any recurrence of the cancer.
A blood sample is taken from the patient and sent to a laboratory for analysis. The results are usually reported as a numerical value, with higher levels indicating a higher likelihood of lung cancer.
It’s important to note that while the CYFRA 21-1 test is a useful tool in the diagnosis and management of lung cancer, it is not definitive and should be used in conjunction with other clinical and diagnostic information.
If you have any concerns about lung cancer or are experiencing symptoms, it is recommended to consult with a healthcare professional who can provide appropriate guidance and testing options.
| Test Name | CA CYFRA 21-1 LUNG CANCER MARKER Test |
|---|---|
| Components | |
| Price | 640.0 AED |
| Sample Condition | 2 mL (0.5 mL min.) serum from 1 SST. Ship refrigerated or frozen. Provide brief clinical history. |
| Report Delivery | 1 week |
| Method | Electrochemiluminescence |
| Test type | Cancer |
| Doctor | Oncologist, Chest Physician |
| Test Department: | |
| Pre Test Information | Provide brief clinical history. |
| Test Details | CYFRA 21-1 is a tumor marker used for the detection and monitoring of lung cancer. It measures the levels of cytokeratin 19 fragments in the blood, which are released by lung cancer cells. The CYFRA 21-1 test is commonly used in combination with other diagnostic tests, such as imaging scans and biopsies, to help diagnose lung cancer and determine its stage. It can also be used to monitor the effectiveness of treatment and detect any recurrence of the cancer. A blood sample is taken from the patient and sent to a laboratory for analysis. The results are usually reported as a numerical value, with higher levels indicating a higher likelihood of lung cancer. It’s important to note that while the CYFRA 21-1 test is a useful tool in the diagnosis and management of lung cancer, it is not definitive and should be used in conjunction with other clinical and diagnostic information. If you have any concerns about lung cancer or are experiencing symptoms, it is recommended to consult with a healthcare professional who can provide appropriate guidance and testing options. |
